FR941028-2-00211 FR941028-2-00109 70. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968&hyph;75. 71. Canessa PA, Fasano L, Lavecchia MA, Torraca A, Schiattone ML. Tuberculin skin test in asymptomatic HIV seropositive carriers [Letter]. Chest 1989;96:1215&hyph;6. 72. CDC. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40(No. RR&hyph;5). 73. Snider DE, Farer LS. Package inserts for antituberculosis drugs and tuberculins. Am Rev Respir Dis 1985;131:809&hyph;10. 74. Snider DE Jr. Bacille Calmette-Gu√©rin vaccinations and tuberculin skin test. JAMA 1985;253:3438&hyph;9. 75. CDC. Use of BCG vaccines in the control of TB: a joint statement by the ACIP and the Advisory Committee for the Elimination of Tuberculosis. MMWR 1988;37:663&hyph;4,669&hyph;75. 76. Thompson NJ, Glassroth JL, Snider DE Jr, Farer LS. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979;119:587&hyph;97. 77. Des Prez RM, Heim CR. Mycobacterium tuberculosis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1877&hyph;906. 78. Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985;131:393&hyph;6. 79. Kiehn TE, Cammarata R. Laboratory diagnosis of mycobacterial infection in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1986;24:708&hyph;11. 80. Crawford JT, Eisenach KD, Bates JH. Diagnosis of tuberculosis: present and future. Semin Respir Infect 1989;4:171&hyph;81. 81. Moulding TS, Redeker AG, Kanel GC. Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis 1989;140:700&hyph;5. 82. Snider DE Jr, Layde PM, Johnson MW, Lyle MA. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65&hyph;79. 83. Snider D. Pregnancy and tuberculosis. Chest 1984;86(suppl):10S&hyph;13S. 84. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992;101:1114&hyph;20. 85. Glassroth JL, White MC, Snider DE Jr. An assessment of the possible association of isoniazid with human cancer deaths. Am Rev Respir Dis 1977;116:1065&hyph;74. 86. Glassroth JL, Snider DE Jr, Comstock GW. Urinary tract cancer and isoniazid. Am Rev Respir Dis 1977;116:331&hyph;3. 87. Costello HD, Snider DE Jr. The incidence of cancer among participants in a controlled, randomized isoniazid preventive therapy trial. Am J Epidemiol 1980;111:67&hyph;74. 88. CDC. The use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990;39 (No. RR&hyph;8):9&hyph;12. 89. CDC. Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41(No. RR&hyph;11):59&hyph;71. 90. American Thoracic Society/CDC. Treatment of tuberculosis and tuberculosis infection in adults and children, 1986. Am Rev Respir Dis 1986;134:355&hyph;63. 91. American Thoracic Society/CDC. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1624&hyph;35. 92. Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992;145:494&hyph;7. 93. Small PM, Shafer RW, Hopewell PC, et al. Exogenous infection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137&hyph;44. 94. Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med 1989;10:341&hyph;53. 95. Goble M. Drug-resistant tuberculosis. Semin Respir Infect 1986;1:220&hyph;9. 96. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527&hyph;32. 97. Simone PM, Iseman MD. Drug-resistant tuberculosis: a deadly_and growing_danger. J Respir Dis 1992;13:960&hyph;71.
